The company
Madrigal Pharmaceuticals, Inc.
MDGL · Nasdaq
MDGL stood above a rising 150-day average in 31 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 12.8% below that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 3
- Industry in uptrend
- 32% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $121.6M
- Officials’ trades on record
- 1
- Institutions holding
- 385 (+33)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 31 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
1 disclosed lines: House 1, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $1k–$15k | 10 Apr 2023filed 19 May 2023 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| William John SiboldPresident and CEO | sold | 60at $533.09 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 106at $534.06 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 218at $535.94 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 160at $537.62 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 687at $540.59 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 368at $541.64 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 1,202at $542.60 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 1,539at $544.02 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 761at $544.83 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 120at $546.38 | 11 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 131at $527.88 | 9 Sep 2026filed 11 Sep 2026 |
| William John SiboldPresident and CEO | sold | 347at $529.27 | 9 Sep 2026filed 11 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BAKER BROS. ADVISORS LPadded · filed 14 Aug 2026 | 2,143,131$1.2B | +1,430+0.1% |
| RTW INVESTMENTS, LPunchanged · filed 14 Aug 2026 | 1,993,687$1.1B | 00.0% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 1,936,099$1.0B | +1,936,099 |
| Avoro Capital Advisors LLCadded · filed 14 Aug 2026 | 1,833,333$984.4M | +15,152+0.8% |
| PAULSON & CO. INC.reduced · filed 14 Aug 2026 | 1,340,020$719.5M | -52,168−3.7% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 1,200,770$644.8M | -359,195−23.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 835,668$448.7M | +8,524+1.0% |
| WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 2026 | 825,714$443.4M | +130,756+18.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 781,731$419.8M | -59,414−7.1% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 527,057$283.0M | -82,468−13.5% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.